Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.17
(2.41%)
HKD 0.17
(2.41%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6.59 Million HKD | -18.35% |
| 2022 | 8.07 Million HKD | -27.55% |
| 2021 | 11.14 Million HKD | -26.62% |
| 2020 | 15.18 Million HKD | 4.18% |
| 2019 | 14.58 Million HKD | -21.57% |
| 2018 | 18.58 Million HKD | 17.57% |
| 2017 | 15.81 Million HKD | 72.1% |
| 2016 | 9.18 Million HKD | -53.85% |
| 2015 | 19.9 Million HKD | -41.41% |
| 2014 | 33.97 Million HKD | -6.1% |
| 2013 | 36.18 Million HKD | 260.04% |
| 2012 | 10.05 Million HKD | -60.55% |
| 2011 | 25.47 Million HKD | -71.76% |
| 2010 | 90.19 Million HKD | -81.36% |
| 2009 | 483.94 Million HKD | 29.24% |
| 2008 | 374.44 Million HKD | 18.11% |
| 2007 | 317.04 Million HKD | 281.47% |
| 2006 | 83.11 Million HKD | 159.49% |
| 2005 | 32.02 Million HKD | 10.21% |
| 2004 | 29.06 Million HKD | -0.11% |
| 2003 | 29.09 Million HKD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 FY | 6.59 Million HKD | -18.35% |
| 2023 Q1 | 1.86 Million HKD | -52.67% |
| 2023 Q2 | 3.72 Million HKD | 100.0% |
| 2023 Q3 | 1.43 Million HKD | -61.55% |
| 2023 Q4 | 2.86 Million HKD | 100.0% |
| 2022 Q3 | 1.96 Million HKD | -52.43% |
| 2022 Q4 | 3.93 Million HKD | 100.0% |
| 2022 Q1 | 2.06 Million HKD | -54.15% |
| 2022 Q2 | 4.13 Million HKD | 100.0% |
| 2022 FY | 8.07 Million HKD | -27.55% |
| 2021 FY | 11.14 Million HKD | -26.62% |
| 2021 Q1 | 3.31 Million HKD | -58.74% |
| 2021 Q2 | 6.63 Million HKD | 100.0% |
| 2021 Q3 | 2.25 Million HKD | -65.98% |
| 2021 Q4 | 4.51 Million HKD | 100.0% |
| 2020 Q2 | 7.15 Million HKD | 100.0% |
| 2020 FY | 15.18 Million HKD | 4.18% |
| 2020 Q3 | 4.01 Million HKD | -43.81% |
| 2020 Q1 | 3.57 Million HKD | 3.53% |
| 2020 Q4 | 8.03 Million HKD | 100.0% |
| 2019 FY | 14.58 Million HKD | -21.57% |
| 2019 Q1 | 5.56 Million HKD | 30.34% |
| 2019 Q2 | 11.12 Million HKD | 100.0% |
| 2019 Q3 | 1.72 Million HKD | -84.48% |
| 2019 Q4 | 3.45 Million HKD | 100.0% |
| 2018 Q3 | 4.26 Million HKD | -15.09% |
| 2018 Q4 | 4.26 Million HKD | 0.0% |
| 2018 Q2 | 5.02 Million HKD | 0.0% |
| 2018 Q1 | 5.02 Million HKD | 65.29% |
| 2018 FY | 18.58 Million HKD | 17.57% |
| 2017 FY | 15.81 Million HKD | 72.1% |
| 2017 Q3 | 3.04 Million HKD | -37.49% |
| 2017 Q2 | 4.86 Million HKD | 0.0% |
| 2017 Q1 | 4.86 Million HKD | 209.74% |
| 2017 Q4 | 3.04 Million HKD | 0.0% |
| 2016 Q4 | 1.57 Million HKD | 0.0% |
| 2016 Q1 | 3.02 Million HKD | 18.76% |
| 2016 Q2 | 3.02 Million HKD | 0.0% |
| 2016 Q3 | 1.57 Million HKD | -48.05% |
| 2016 FY | 9.18 Million HKD | -53.85% |
| 2015 Q1 | 7.4 Million HKD | -6.17% |
| 2015 Q3 | 2.54 Million HKD | -65.64% |
| 2015 Q2 | 7.4 Million HKD | 0.0% |
| 2015 Q4 | 2.54 Million HKD | 0.0% |
| 2015 FY | 19.9 Million HKD | -41.41% |
| 2014 Q1 | 9.09 Million HKD | 0.0% |
| 2014 FY | 33.97 Million HKD | -6.1% |
| 2014 Q4 | 7.89 Million HKD | 0.0% |
| 2014 Q3 | 7.89 Million HKD | -13.16% |
| 2014 Q2 | 9.09 Million HKD | 0.0% |
| 2013 FY | 36.18 Million HKD | 260.04% |
| 2013 Q2 | 6.44 Million HKD | 88.65% |
| 2013 Q4 | - HKD | 0.0% |
| 2013 Q1 | 3.41 Million HKD | -19.86% |
| 2012 Q2 | 36.5 Thousand HKD | 0.0% |
| 2012 Q4 | 4.26 Million HKD | 11571.23% |
| 2012 Q3 | 36.5 Thousand HKD | 0.0% |
| 2012 FY | 10.05 Million HKD | -60.55% |
| 2011 FY | 25.47 Million HKD | -71.76% |
| 2010 FY | 90.19 Million HKD | -81.36% |
| 2009 FY | 483.94 Million HKD | 29.24% |
| 2008 FY | 374.44 Million HKD | 18.11% |
| 2007 FY | 317.04 Million HKD | 281.47% |
| 2006 FY | 83.11 Million HKD | 159.49% |
| 2005 FY | 32.02 Million HKD | 10.21% |
| 2004 FY | 29.06 Million HKD | -0.11% |
| 2003 FY | 29.09 Million HKD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 336.01 Million HKD | 98.038% |
| China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | 96.357% |
| Prosperous Future Holdings Limited | 470.33 Million HKD | 98.598% |
| Huasheng International Holding Limited | 565.9 Million HKD | 98.835% |
| Fourace Industries Group Holdings Limited | 268.02 Million HKD | 97.54% |
| Evergreen Products Group Limited | 979.24 Million HKD | 99.327% |
| EC Healthcare | 4.21 Billion HKD | 99.843% |
| Ming Fai International Holdings Limited | 2.06 Billion HKD | 99.681% |
| Blue Moon Group Holdings Limited | 7.32 Billion HKD | 99.91% |
| SuperRobotics Holdings Limited | 15.08 Million HKD | 56.283% |
| Takbo Group Holdings Limited | 215.59 Million HKD | 96.942% |
| Hyfusin Group Holdings Limited | 866.25 Million HKD | 99.239% |